GSK-3 inhibitor CP21R7, Purity ≥98%

Synonym: 125314-13-8; CP21; GSK-3 inhibitor

CAS Number: 125314-13-8
Compound CID: 5327711

Product Size

1 mg; 5 mg; 10 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CP21R7, soluble in DMSO and warmed ethanol and insoluble in water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3β and PKCα.

Molecular Weight

317.34

Molecular Formula

C₁₉H₁₅N₃O₂

Targets

GSK-3β: 1.8 nM; PKCα: 1900 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 62 mg/mL (195.37 mM); Water: Insoluble; Warmed ethanol: 1 mg/mL (3.15 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

CP21R7 is used to explore its inhibitory effects on GSK-3 in biomedical research.